General Statement of Disclosure:

CONSULTING FEES/HONORARIA: LivaNova(MODEST), Bodyport(MODEST), NovoNordisk(MODEST) RESEARCH/RESEARCH GRANTS: Novartis Corporation(SIGNIFICANT), NHLBI(SIGNIFICANT), American Regent, Inc(MODEST), Bodyport(SIGNIFICANT), Story Health(SIGNIFICANT), Biofourmis(SIGNIFICANT), Cytokinetics(MODEST) OTHER FINANCIAL BENEFIT: Natera(MODEST), Zoll(MODEST), Myovant(MODEST)

View Full Disclosure